Cargando…
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study
BACKGROUND: A paradigm shift has occurred in cancer chemotherapy from tumor‐specific treatment with cytotoxic agents to personalized medicine with molecular‐targeted drugs. Thus, it is essential to identify genomic alterations and molecular features to recommend effective targeted molecular medicine...
Autores principales: | Shirota, Hidekazu, Komine, Keigo, Takahashi, Masanobu, Takahashi, Shin, Miyauchi, Eisaku, Niizuma, Hidetaka, Tada, Hiroshi, Shimada, Muneaki, Niihori, Tetsuya, Aoki, Yoko, Sugiyama, Ikuko, Kawamura, Maako, Yasuda, Jun, Suzuki, Shuhei, Iwaya, Takeshi, Saito, Motonobu, Saito, Tsuyoshi, Shibata, Hiroyuki, Furukawa, Toru, Ishioka, Chikashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028111/ https://www.ncbi.nlm.nih.gov/pubmed/36251535 http://dx.doi.org/10.1002/cam4.5349 |
Ejemplares similares
-
Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
por: Hiraide, Sakura, et al.
Publicado: (2019) -
Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
por: Hiraide, Sakura, et al.
Publicado: (2021) -
Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study
por: Imai, Hiroo, et al.
Publicado: (2019) -
Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients
por: Imai, Hiroo, et al.
Publicado: (2020) -
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
por: Saijo, Ken, et al.
Publicado: (2022)